Get notified of page updates

Enroll in Research > Research Search & Enroll Tool > Treating Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer with Chemotherapy and Rucaparib

Glossary on

off

Printer Friendly Page

Treating Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer with Chemotherapy and Rucaparib

Clinicaltrials.gov identifier:
NCT03337087

Metastatic colorectal, pancreatic, gastroesophageal or biliary tract cancer

Study Contact Information:

For additional information, please contact the coordinating center at Mayo Clinic by phone: 855-776-0015

Principal Investigator: Tanios S. Bekaii-Saab

Treating Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer with Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib

About the Study

This study is focused on patients with pancreatic, colorectal, gastroesophageal, or biliary (bile duct) cancer that has spread to other places in the body (metastasized). NOTE: This study is no longer enrolling patients.

This Study is Open To:

NOTE: This study is no longer enrolling patients.

This Study is Not Open To:

NOTE: This study is no longer enrolling patients.